OliX Pharmaceuticals secures KRW 110 billion investment from L’Oréal venture fund and Weis

June 4, 2026

OliX Pharmaceuticals has raised KRW110 billion from L’Oréal’s BOLD venture fund and Weiss Asset Management to advance RNAi-based beauty and wellness innovation.

Search

RECENT PRESS RELEASES

The Tech Download: Anthropic’s IPO sets up first big test of AI boom valuations

SWI Editorial Staff2026-06-05T04:00:01-07:00June 5, 2026|

Amazon Pours $10 Billion Into Europe: New Robots, 25,000 New Jobs

SWI Editorial Staff2026-06-05T04:00:00-07:00June 5, 2026|

Ramp’s valuation jumps to $44bn following $750m round

SWI Editorial Staff2026-06-05T03:59:46-07:00June 5, 2026|

Warren Buffett Has Been Investing for More Than 60 Years. Only 5 Were Worth Getting Excited About.

SWI Editorial Staff2026-06-05T03:57:00-07:00June 5, 2026|

Trump weighs in on right-to-repair debate after meeting with automakers, dealers

SWI Editorial Staff2026-06-05T03:56:30-07:00June 5, 2026|

Warren Buffett disciple Guy Spier built career on value investing. A rare cancer changed everything

SWI Editorial Staff2026-06-05T03:55:02-07:00June 5, 2026|